Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H26N2O2S |
Molecular Weight | 382.519 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
InChI
InChIKey=PWVXXGRKLHYWKM-LJQANCHMSA-N
InChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1
Molecular Formula | C22H26N2O2S |
Molecular Weight | 382.519 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:17:27 UTC 2023
by
admin
on
Fri Dec 15 16:17:27 UTC 2023
|
Record UNII |
22QOO9B8KI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
343
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
||
|
NCI_THESAURUS |
C47794
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
||
|
WHO-ATC |
N02CC06
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
||
|
NDF-RT |
N0000175764
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
||
|
WHO-VATC |
QN02CC06
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
||
|
NDF-RT |
N0000175763
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
||
|
NDF-RT |
N0000175765
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Eletriptan
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
DTXSID9046861
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
100000080522
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
SUB06482MIG
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
DB00216
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
CHEMBL1510
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
22QOO9B8KI
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
C65509
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
143322-58-1
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
995
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
C115647
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
7426
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
50922
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
ELETRIPTAN
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
22QOO9B8KI
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
m4867
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | Merck Index | ||
|
231049
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | RxNorm | ||
|
40
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY | |||
|
77993
Created by
admin on Fri Dec 15 16:17:27 UTC 2023 , Edited by admin on Fri Dec 15 16:17:27 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Eletriptan binds with high affinity to 5-HT1B, 5-HT1D and 5-HT1F receptors, has modest affinity for 5-HT1A, 5-HT1E, 5-HT2B and 5-HT7 receptors
BINDING
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> AGONIST |
Eletriptan binds with high affinity to 5-HT1B, 5-HT1D and 5-HT1F receptors, has modest affinity for 5-HT1A, 5-HT1E, 5-HT2B and 5-HT7 receptors
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MINOR
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> AGONIST |
Eletriptan binds with high affinity to 5-HT1B, 5-HT1D and 5-HT1F receptors, has modest affinity for 5-HT1A, 5-HT1E, 5-HT2B and 5-HT7 receptors
|
||
|
TARGET -> AGONIST |
Eletriptan binds with high affinity to 5-HT1B, 5-HT1D and 5-HT1F receptors, has modest affinity for 5-HT1A, 5-HT1E, 5-HT2B and 5-HT7 receptors
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
MINOR
|
||
|
TARGET -> AGONIST |
Eletriptan binds with high affinity to 5-HT1B, 5-HT1D and 5-HT1F receptors, has modest affinity for 5-HT1A, 5-HT1E, 5-HT2B and 5-HT7 receptors
BINDING
|
||
|
TRANSPORTER -> SUBSTRATE |
EFFLUX RATIO
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||